373 related articles for article (PubMed ID: 29157145)
1. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
4. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of Clostridium difficile treatments: a systematic review.
Drekonja DM; Butler M; MacDonald R; Bliss D; Filice GA; Rector TS; Wilt TJ
Ann Intern Med; 2011 Dec; 155(12):839-47. PubMed ID: 22184691
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
[TBL] [Abstract][Full Text] [Related]
8. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
10. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
11. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
Wilcox MH; Howe R
J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
[TBL] [Abstract][Full Text] [Related]
12. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with failure of metronidazole in Clostridium difficile-associated disease.
Fernandez A; Anand G; Friedenberg F
J Clin Gastroenterol; 2004; 38(5):414-8. PubMed ID: 15100520
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Huggan PJ; Murdoch DR
Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
[No Abstract] [Full Text] [Related]
15. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
[No Abstract] [Full Text] [Related]
16. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Lam SW; Bass SN; Neuner EA; Bauer SR
Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
[TBL] [Abstract][Full Text] [Related]
17. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Bishara J; Wattad M; Paul M
Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
[No Abstract] [Full Text] [Related]
19. [Individualized treatment strategies for Clostridium difficile infections].
Solbach P; Dersch P; Bachmann O
Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
[TBL] [Abstract][Full Text] [Related]
20. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]